Coagulation Analyzer Market Analysis By Product, By Technology (Mechanical, Electrochemical) By Test Types (APTT, D-Dimer, Fibrinogen, PT) By End Use (Hospitals, Research Institutes) & Segment Forecasts, 2013 - 2024
The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.
The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.
Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:
Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
Automatic reflex testing, repeat testing, and redilution
Further key findings from the study suggest:
Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.
The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.
Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:
Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
Automatic reflex testing, repeat testing, and redilution
Further key findings from the study suggest:
Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation
4.2 Market size and growth prospects
4.2.1 Market driver analysis
4.2.2 Market restraint analysis
4.3 Key Opportunities Prioritized
4.4 Industry Analysis Porter’s
4.5 PESTEL Analysis
CHAPTER 5 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Coagulation analyzers and reagents market: Product movement analysis
5.2 Analyzers
5.2.1 Analyzers market, 2013 - 2024 (USD Million)
5.2.2 Clinical LaboratoryAnalyzers market, 2013 - 2024 (USD Million)
5.2.3 Point of CareAnalyzers market, 2013 - 2024 (USD Million)
5.3 Consumables
5.3.1 Consumables market, 2013 - 2024 (USD Million)
5.3.1.1 Reagents market, 2013 - 2024 (USD Million)
5.3.1.2 Stains market, 2013 - 2024 (USD Million)
CHAPTER 6 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1 Coagulation analyzers and reagents market: Technology movement analysis
6.2 Mechanical
6.2.1 Mechanical market, 2013 - 2024 (USD Million)
6.3 Electrochemical
6.3.1 Electrochemical market, 2013 - 2024 (USD Million)
6.4 Optical
6.4.1 Optical market, 2013 - 2024 (USD Million)
6.4.2 Photo optical/Chromogenic/Immuno market, 2013 - 2024 (USD Million)
6.4.3 Others/Nephelometric market, 2013 - 2024 (USD Million)
CHAPTER 7 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: TEST TYPE ESTIMATES & TREND ANALYSIS
7.1 Coagulation analyzers and reagents market: Test Type movement analysis
7.2 APTT
7.2.1 APPT market, 2013 - 2024 (USD Million)
7.3 D-DImer
7.3.1 D-Dimer market, 2013 - 2024 (USD Million)
7.4 Fibrinogen
7.4.1 Fibrinogen market, 2013 - 2024 (USD Million)
7.5 ProthrombinTime (PT) & Thrombin Time Test
7.5.1 ProthrombinTime (PT) & Thrombin Time Testmarket, 2013 - 2024 (USD Million)
7.6 Others
7.6.1 Others market, 2013 - 2024 (USD Million)
CHAPTER 8 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: END-USER ESTIMATES & TREND ANALYSIS
8.1 Coagulation analyzers and reagents market: End-user movement analysis
8.2 Hospital
8.2.1 Hospital market, 2013 - 2024 (USD Million)
8.3 Research Institute
8.3.1 Research Institute market, 2013 - 2024 (USD Million)
8.4 Diagnostic Centres
8.4.1 Diagnostic Centres market, 2013 - 2024 (USD Million)
8.5 Others
8.5.1 Others market, 2013 - 2024 (USD Million)
CHAPTER 9 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE, DELIVERY MODE, COMPONENT & END-USERS
9.1 Coagulation analyzers and reagents market share by region, 2015 & 2024
9.2 North America
9.2.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.2.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.2.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.2.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.2.4.1 U.S.
9.2.4.2 Canada
9.3 Europe
9.3.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.3.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.3.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.3.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.3.4.1 UK
9.3.4.2 Germany
9.4 Asia Pacific
9.4.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.4.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.4.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.4.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.4.4.1 Japan
9.4.4.2 China
9.5 Latin America
9.5.1Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.5.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.5.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.5.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.5.4.1 Brazil
9.5.4.2 Mexico
9.6 MEA
9.6.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.6.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.6.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.6.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.6.4.1 South Africa
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Strategy framework
10.2 Company Profiles
10.2.1 Siemens Healthcare
10.2.1.1 Company Overview
10.2.1.2 Financial Performance
10.2.1.3 Product Benchmarking
10.2.1.4 Strategic Initiatives
10.2.2 Roche Diagnostics
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Thermo Fischer Scientific
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 Instrumentation Laboratory
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 Sysmex Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 International Technidyne Corporation
10.2.6.1 Company Overview
10.2.6.2 Financial Performance
10.2.6.3 Product Benchmarking
10.2.6.4 Strategic Initiatives
10.2.7 Alere Inc.
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 NIHON KOHDEN
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 Beckman Coulter Inc
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
1.1 Information procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET SNAPSHOT
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Segmentation
4.2 Market size and growth prospects
4.2.1 Market driver analysis
4.2.2 Market restraint analysis
4.3 Key Opportunities Prioritized
4.4 Industry Analysis Porter’s
4.5 PESTEL Analysis
CHAPTER 5 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: PRODUCT ESTIMATES & TREND ANALYSIS
5.1 Coagulation analyzers and reagents market: Product movement analysis
5.2 Analyzers
5.2.1 Analyzers market, 2013 - 2024 (USD Million)
5.2.2 Clinical LaboratoryAnalyzers market, 2013 - 2024 (USD Million)
5.2.3 Point of CareAnalyzers market, 2013 - 2024 (USD Million)
5.3 Consumables
5.3.1 Consumables market, 2013 - 2024 (USD Million)
5.3.1.1 Reagents market, 2013 - 2024 (USD Million)
5.3.1.2 Stains market, 2013 - 2024 (USD Million)
CHAPTER 6 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1 Coagulation analyzers and reagents market: Technology movement analysis
6.2 Mechanical
6.2.1 Mechanical market, 2013 - 2024 (USD Million)
6.3 Electrochemical
6.3.1 Electrochemical market, 2013 - 2024 (USD Million)
6.4 Optical
6.4.1 Optical market, 2013 - 2024 (USD Million)
6.4.2 Photo optical/Chromogenic/Immuno market, 2013 - 2024 (USD Million)
6.4.3 Others/Nephelometric market, 2013 - 2024 (USD Million)
CHAPTER 7 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: TEST TYPE ESTIMATES & TREND ANALYSIS
7.1 Coagulation analyzers and reagents market: Test Type movement analysis
7.2 APTT
7.2.1 APPT market, 2013 - 2024 (USD Million)
7.3 D-DImer
7.3.1 D-Dimer market, 2013 - 2024 (USD Million)
7.4 Fibrinogen
7.4.1 Fibrinogen market, 2013 - 2024 (USD Million)
7.5 ProthrombinTime (PT) & Thrombin Time Test
7.5.1 ProthrombinTime (PT) & Thrombin Time Testmarket, 2013 - 2024 (USD Million)
7.6 Others
7.6.1 Others market, 2013 - 2024 (USD Million)
CHAPTER 8 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: END-USER ESTIMATES & TREND ANALYSIS
8.1 Coagulation analyzers and reagents market: End-user movement analysis
8.2 Hospital
8.2.1 Hospital market, 2013 - 2024 (USD Million)
8.3 Research Institute
8.3.1 Research Institute market, 2013 - 2024 (USD Million)
8.4 Diagnostic Centres
8.4.1 Diagnostic Centres market, 2013 - 2024 (USD Million)
8.5 Others
8.5.1 Others market, 2013 - 2024 (USD Million)
CHAPTER 9 COAGULATION ANALYZERS & REAGENTS MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE, DELIVERY MODE, COMPONENT & END-USERS
9.1 Coagulation analyzers and reagents market share by region, 2015 & 2024
9.2 North America
9.2.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.2.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.2.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.2.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.2.4.1 U.S.
9.2.4.2 Canada
9.3 Europe
9.3.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.3.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.3.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.3.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.3.4.1 UK
9.3.4.2 Germany
9.4 Asia Pacific
9.4.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.4.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.4.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.4.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.4.4.1 Japan
9.4.4.2 China
9.5 Latin America
9.5.1Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.5.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.5.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.5.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.5.4.1 Brazil
9.5.4.2 Mexico
9.6 MEA
9.6.1 Coagulation analyzers and reagents market estimates and forecasts, by product 2013 - 2024
9.6.2 Coagulation analyzers and reagents market estimates and forecasts, by test type 2013 - 2024
9.6.3 Coagulation analyzers and reagents market estimates and forecasts, by technology 2013 - 2024
9.6.4 Coagulation analyzers and reagents market estimates and forecasts, by end-users 2013 - 2024
9.6.4.1 South Africa
CHAPTER 10 COMPETITIVE LANDSCAPE
10.1 Strategy framework
10.2 Company Profiles
10.2.1 Siemens Healthcare
10.2.1.1 Company Overview
10.2.1.2 Financial Performance
10.2.1.3 Product Benchmarking
10.2.1.4 Strategic Initiatives
10.2.2 Roche Diagnostics
10.2.2.1 Company Overview
10.2.2.2 Financial Performance
10.2.2.3 Product Benchmarking
10.2.2.4 Strategic Initiatives
10.2.3 Thermo Fischer Scientific
10.2.3.1 Company Overview
10.2.3.2 Financial Performance
10.2.3.3 Product Benchmarking
10.2.3.4 Strategic Initiatives
10.2.4 Instrumentation Laboratory
10.2.4.1 Company Overview
10.2.4.2 Financial Performance
10.2.4.3 Product Benchmarking
10.2.4.4 Strategic Initiatives
10.2.5 Sysmex Corporation
10.2.5.1 Company Overview
10.2.5.2 Financial Performance
10.2.5.3 Product Benchmarking
10.2.5.4 Strategic Initiatives
10.2.6 International Technidyne Corporation
10.2.6.1 Company Overview
10.2.6.2 Financial Performance
10.2.6.3 Product Benchmarking
10.2.6.4 Strategic Initiatives
10.2.7 Alere Inc.
10.2.7.1 Company Overview
10.2.7.2 Financial Performance
10.2.7.3 Product Benchmarking
10.2.7.4 Strategic Initiatives
10.2.8 NIHON KOHDEN
10.2.8.1 Company Overview
10.2.8.2 Financial Performance
10.2.8.3 Product Benchmarking
10.2.8.4 Strategic Initiatives
10.2.9 Beckman Coulter Inc
10.2.9.1 Company Overview
10.2.9.2 Financial Performance
10.2.9.3 Product Benchmarking
10.2.9.4 Strategic Initiatives
LIST OF TABLES
TABLE 1 Coagulation analyzers & reagents market - Industry snapshot
TABLE 2 Coagulation analyzers & reagents market, by type, 2013 - 2024 (USD Million)
TABLE 3 Coagulation analyzers & reagents market, by treatment, 2013 - 2024 (USD Million)
TABLE 4 Coagulation analyzers & reagents market, by therapy, 2013 - 2024 (USD Million)
TABLE 5 Coagulation analyzers & reagents market, by region, 2013 - 2024 (USD Million)
TABLE 6 Coagulation analyzers & reagents market - Key market driver analysis
TABLE 7 Coagulation analyzers & reagents market - Key market restraint analysis
TABLE 8 North America market, by product 2013 - 2024 (USD Million)
TABLE 9 North America market, by test type 2013 - 2024 (USD Million)
TABLE 10 North America market, by technology 2013 - 2024 (USD Million)
TABLE 11 North America market, by end users 2013 - 2024 (USD Million)
TABLE 12 U.S. market, by product 2013 - 2024 (USD Million)
TABLE 13 U.S. market, by test type 2013 - 2024 (USD Million)
TABLE 14 U.S. market, by technology 2013 - 2024 (USD Million)
TABLE 15 U.S. market, by end users 2013 - 2024 (USD Million)
TABLE 16 Canada market, by product 2013 - 2024 (USD Million)
TABLE 17 Canada market, by test type 2013 - 2024 (USD Million)
TABLE 18 Canada market, by technology 2013 - 2024 (USD Million)
TABLE 19 Canada market, by end users 2013 - 2024 (USD Million)
TABLE 20 Europe market, by product 2013 - 2024 (USD Million)
TABLE 21 Europe market, by test type 2013 - 2024 (USD Million)
TABLE 22 Europe market, by technology 2013 - 2024 (USD Million)
TABLE 23 Europe market, by end users 2013 - 2024 (USD Million)
TABLE 24 UK market, by product 2013 - 2024 (USD Million)
TABLE 25 UK market, by test type 2013 - 2024 (USD Million)
TABLE 26 UK market, by technology 2013 - 2024 (USD Million)
TABLE 27 UK market, by end users 2013 - 2024 (USD Million)
TABLE 28 Germany market, by product 2013 - 2024 (USD Million)
TABLE 29 Germany market, by test type 2013 - 2024 (USD Million)
TABLE 30 Germany market, by technology 2013 - 2024 (USD Million)
TABLE 31 Germany market, by end users 2013 - 2024 (USD Million)
TABLE 32 Asia Pacific market, by product 2013 - 2024 (USD Million)
TABLE 33 Asia Pacific market, by test type 2013 - 2024 (USD Million)
TABLE 34 Asia Pacific market, by technology 2013 - 2024 (USD Million)
TABLE 35 Asia Pacific market, by end users 2013 - 2024 (USD Million)
TABLE 36 Japan market, by product 2013 - 2024 (USD Million)
TABLE 37 Japan market, by test type 2013 - 2024 (USD Million)
TABLE 38 Japan market, by technology 2013 - 2024 (USD Million)
TABLE 39 Japan market, by end users 2013 - 2024 (USD Million)
TABLE 40 China market, by product 2013 - 2024 (USD Million)
TABLE 41 China market, by test type 2013 - 2024 (USD Million)
TABLE 42 China market, by technology 2013 - 2024 (USD Million)
TABLE 43 Chinamarket, by end users 2013 - 2024 (USD Million)
TABLE 44 Latin America market, by product 2013 - 2024 (USD Million)
TABLE 45 Latin America market, by test type 2013 - 2024 (USD Million)
TABLE 46 Latin America market, by technology 2013 - 2024 (USD Million)
TABLE 47 Latin America market, by end users 2013 - 2024 (USD Million)
TABLE 48 Brazil market, by product 2013 - 2024 (USD Million)
TABLE 49 Brazil market, by test type 2013 - 2024 (USD Million)
TABLE 50 Brazil market, by technology 2013 - 2024 (USD Million)
TABLE 51 Brazil market, by end users 2013 - 2024 (USD Million)
TABLE 52 Mexico market, by product 2013 - 2024 (USD Million)
TABLE 53 Mexico market, by test type 2013 - 2024 (USD Million)
TABLE 54 Mexico market, by technology 2013 - 2024 (USD Million)
TABLE 55 Mexico market, by end users 2013 - 2024 (USD Million)
TABLE 56 MEA market, by product 2013 - 2024 (USD Million)
TABLE 57 MEA market, by test type 2013 - 2024 (USD Million)
TABLE 58 MEA market, by technology 2013 - 2024 (USD Million)
TABLE 59 MEA market, by end users 2013 - 2024 (USD Million)
TABLE 60 South Africa market, by product 2013 - 2024 (USD Million)
TABLE 61 South Africa market, by test type 2013 - 2024 (USD Million)
TABLE 62 South Africa market, by technology 2013 - 2024 (USD Million)
TABLE 63 South Africa market, by end users 2013 - 2024 (USD Million)
TABLE 1 Coagulation analyzers & reagents market - Industry snapshot
TABLE 2 Coagulation analyzers & reagents market, by type, 2013 - 2024 (USD Million)
TABLE 3 Coagulation analyzers & reagents market, by treatment, 2013 - 2024 (USD Million)
TABLE 4 Coagulation analyzers & reagents market, by therapy, 2013 - 2024 (USD Million)
TABLE 5 Coagulation analyzers & reagents market, by region, 2013 - 2024 (USD Million)
TABLE 6 Coagulation analyzers & reagents market - Key market driver analysis
TABLE 7 Coagulation analyzers & reagents market - Key market restraint analysis
TABLE 8 North America market, by product 2013 - 2024 (USD Million)
TABLE 9 North America market, by test type 2013 - 2024 (USD Million)
TABLE 10 North America market, by technology 2013 - 2024 (USD Million)
TABLE 11 North America market, by end users 2013 - 2024 (USD Million)
TABLE 12 U.S. market, by product 2013 - 2024 (USD Million)
TABLE 13 U.S. market, by test type 2013 - 2024 (USD Million)
TABLE 14 U.S. market, by technology 2013 - 2024 (USD Million)
TABLE 15 U.S. market, by end users 2013 - 2024 (USD Million)
TABLE 16 Canada market, by product 2013 - 2024 (USD Million)
TABLE 17 Canada market, by test type 2013 - 2024 (USD Million)
TABLE 18 Canada market, by technology 2013 - 2024 (USD Million)
TABLE 19 Canada market, by end users 2013 - 2024 (USD Million)
TABLE 20 Europe market, by product 2013 - 2024 (USD Million)
TABLE 21 Europe market, by test type 2013 - 2024 (USD Million)
TABLE 22 Europe market, by technology 2013 - 2024 (USD Million)
TABLE 23 Europe market, by end users 2013 - 2024 (USD Million)
TABLE 24 UK market, by product 2013 - 2024 (USD Million)
TABLE 25 UK market, by test type 2013 - 2024 (USD Million)
TABLE 26 UK market, by technology 2013 - 2024 (USD Million)
TABLE 27 UK market, by end users 2013 - 2024 (USD Million)
TABLE 28 Germany market, by product 2013 - 2024 (USD Million)
TABLE 29 Germany market, by test type 2013 - 2024 (USD Million)
TABLE 30 Germany market, by technology 2013 - 2024 (USD Million)
TABLE 31 Germany market, by end users 2013 - 2024 (USD Million)
TABLE 32 Asia Pacific market, by product 2013 - 2024 (USD Million)
TABLE 33 Asia Pacific market, by test type 2013 - 2024 (USD Million)
TABLE 34 Asia Pacific market, by technology 2013 - 2024 (USD Million)
TABLE 35 Asia Pacific market, by end users 2013 - 2024 (USD Million)
TABLE 36 Japan market, by product 2013 - 2024 (USD Million)
TABLE 37 Japan market, by test type 2013 - 2024 (USD Million)
TABLE 38 Japan market, by technology 2013 - 2024 (USD Million)
TABLE 39 Japan market, by end users 2013 - 2024 (USD Million)
TABLE 40 China market, by product 2013 - 2024 (USD Million)
TABLE 41 China market, by test type 2013 - 2024 (USD Million)
TABLE 42 China market, by technology 2013 - 2024 (USD Million)
TABLE 43 Chinamarket, by end users 2013 - 2024 (USD Million)
TABLE 44 Latin America market, by product 2013 - 2024 (USD Million)
TABLE 45 Latin America market, by test type 2013 - 2024 (USD Million)
TABLE 46 Latin America market, by technology 2013 - 2024 (USD Million)
TABLE 47 Latin America market, by end users 2013 - 2024 (USD Million)
TABLE 48 Brazil market, by product 2013 - 2024 (USD Million)
TABLE 49 Brazil market, by test type 2013 - 2024 (USD Million)
TABLE 50 Brazil market, by technology 2013 - 2024 (USD Million)
TABLE 51 Brazil market, by end users 2013 - 2024 (USD Million)
TABLE 52 Mexico market, by product 2013 - 2024 (USD Million)
TABLE 53 Mexico market, by test type 2013 - 2024 (USD Million)
TABLE 54 Mexico market, by technology 2013 - 2024 (USD Million)
TABLE 55 Mexico market, by end users 2013 - 2024 (USD Million)
TABLE 56 MEA market, by product 2013 - 2024 (USD Million)
TABLE 57 MEA market, by test type 2013 - 2024 (USD Million)
TABLE 58 MEA market, by technology 2013 - 2024 (USD Million)
TABLE 59 MEA market, by end users 2013 - 2024 (USD Million)
TABLE 60 South Africa market, by product 2013 - 2024 (USD Million)
TABLE 61 South Africa market, by test type 2013 - 2024 (USD Million)
TABLE 62 South Africa market, by technology 2013 - 2024 (USD Million)
TABLE 63 South Africa market, by end users 2013 - 2024 (USD Million)
LIST OF FIGURES
FIG. 1 Global Coagulation analyzers & reagents: Market segmentation
FIG. 2 Global Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 3 Coagulation analyzers & reagents: Market dynamics
FIG. 4 Coagulation analyzers & reagents market: Porter’s analysis
FIG. 5 Key opportunities prioritized
FIG. 6 Coagulation analyzers & reagents market: PESTEL Analysis
FIG. 7 Coagulation analyzers & reagents market share, by product, 2015 &2024
FIG. 8 Analyzers market, 2013 - 2024 (USD Million)
FIG. 9 Consumables market, 2013 - 2024 (USD Million)
FIG. 10 Clinical Laboratory Analyzers market, 2013 - 2024 (USD Million)
FIG. 11 Point of Care Analyzers market, 2013 - 2024 (USD Million)
FIG. 12 Reagents market, 2013 - 2024 (USD Million)
FIG. 13 Stains market, 2013 - 2024 (USD Million)
FIG. 14 Coagulation analyzers & reagents market share, by test type, 2015 &2024
FIG. 15 APTT market, 2013 - 2024 (USD Million)
FIG. 16 D-Dimer market, 2013 - 2024 (USD Million)
FIG. 17 Fibrinogen market, 2013 - 2024 (USD Million)
FIG. 18 Prothrombin Time (PT) & Thrombin Time Test market, 2013 - 2024 (USD Million)
FIG. 19 Others market, 2013 - 2024 (USD Million)
FIG. 20 Coagulation analyzers & reagents market share, by technology, 2015 &2024
FIG. 21 Mechanicalmarket, 2013 - 2024 (USD Million)
FIG. 22 Electrochemical market, 2013 - 2024 (USD Million)
FIG. 23 Optical market, 2013 - 2024 (USD Million)
FIG. 24 Photo optical/Chromogenic/Immuno market, 2013 - 2024 (USD Million)
FIG. 25 Others/Nephelometric market, 2013 - 2024 (USD Million)
FIG. 26 Othersmarket, 2013 - 2024 (USD Million)
FIG. 27 Coagulation analyzers & reagents market share, by end use, 2015 & 2024
FIG. 28 Hospitalmarket, 2013 - 2024 (USD Million)
FIG. 29 Research Institutes market, 2013 - 2024 (USD Million)
FIG. 30 Diagnostics Centers market, 2013 - 2024 (USD Million)
FIG. 31 Others market, 2013 - 2024 (USD Million)
FIG. 32 Coagulation analyzers & reagents market share, by region, 2015 & 2024
FIG. 33 North America Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 34 U.S. Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 35 Canada Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 36 Europe Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 37 UK Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 38 Germany Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 39 Asia-PacificCoagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 40 Japan Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 41 China Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 42 Latin America Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 43 Brazil Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 44 Mexico Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 45 MEA Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 46 South Africa Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 1 Global Coagulation analyzers & reagents: Market segmentation
FIG. 2 Global Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 3 Coagulation analyzers & reagents: Market dynamics
FIG. 4 Coagulation analyzers & reagents market: Porter’s analysis
FIG. 5 Key opportunities prioritized
FIG. 6 Coagulation analyzers & reagents market: PESTEL Analysis
FIG. 7 Coagulation analyzers & reagents market share, by product, 2015 &2024
FIG. 8 Analyzers market, 2013 - 2024 (USD Million)
FIG. 9 Consumables market, 2013 - 2024 (USD Million)
FIG. 10 Clinical Laboratory Analyzers market, 2013 - 2024 (USD Million)
FIG. 11 Point of Care Analyzers market, 2013 - 2024 (USD Million)
FIG. 12 Reagents market, 2013 - 2024 (USD Million)
FIG. 13 Stains market, 2013 - 2024 (USD Million)
FIG. 14 Coagulation analyzers & reagents market share, by test type, 2015 &2024
FIG. 15 APTT market, 2013 - 2024 (USD Million)
FIG. 16 D-Dimer market, 2013 - 2024 (USD Million)
FIG. 17 Fibrinogen market, 2013 - 2024 (USD Million)
FIG. 18 Prothrombin Time (PT) & Thrombin Time Test market, 2013 - 2024 (USD Million)
FIG. 19 Others market, 2013 - 2024 (USD Million)
FIG. 20 Coagulation analyzers & reagents market share, by technology, 2015 &2024
FIG. 21 Mechanicalmarket, 2013 - 2024 (USD Million)
FIG. 22 Electrochemical market, 2013 - 2024 (USD Million)
FIG. 23 Optical market, 2013 - 2024 (USD Million)
FIG. 24 Photo optical/Chromogenic/Immuno market, 2013 - 2024 (USD Million)
FIG. 25 Others/Nephelometric market, 2013 - 2024 (USD Million)
FIG. 26 Othersmarket, 2013 - 2024 (USD Million)
FIG. 27 Coagulation analyzers & reagents market share, by end use, 2015 & 2024
FIG. 28 Hospitalmarket, 2013 - 2024 (USD Million)
FIG. 29 Research Institutes market, 2013 - 2024 (USD Million)
FIG. 30 Diagnostics Centers market, 2013 - 2024 (USD Million)
FIG. 31 Others market, 2013 - 2024 (USD Million)
FIG. 32 Coagulation analyzers & reagents market share, by region, 2015 & 2024
FIG. 33 North America Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 34 U.S. Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 35 Canada Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 36 Europe Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 37 UK Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 38 Germany Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 39 Asia-PacificCoagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 40 Japan Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 41 China Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 42 Latin America Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 43 Brazil Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 44 Mexico Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 45 MEA Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
FIG. 46 South Africa Coagulation analyzers & reagents market, 2013 - 2024 (USD Million)
